Profile data is unavailable for this security.
About the company
Vita Life Sciences Limited (Vita Life) is a pharmaceutical and healthcare company. The Company is involved in formulating, packaging, sales and distributing vitamins and supplements. Its core business is the development and distribution of over-the-counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. Its brand portfolio includes Herbs of Gold, VitaHealth, VitaScience and VitaLife. Herbs of Gold brand produces premium herbal, mineral, vitamin and superfood products. VitaHealth brand offers a comprehensive range of nutritional products that cater to every health need, from inner wellness to outer radiance. VitaScience is a vivacious nutritional supplement brand that offers practitioner strength quality formulations. Its subsidiaries include Vita Healthcare Asia Pacific Sdn Bhd, Herbs of Gold Sdn Bhd and others.
- Revenue in AUD (TTM)78.92m
- Net income in AUD9.41m
- Incorporated1986
- Employees124.00
- LocationVita Life Sciences LtdUnit 1 102 Bath Road, KirraweeSYDNEY 2232AustraliaAUS
- Phone+61 29545-2633
- Fax+61 29545-1311
- Websitehttps://vitalifesciences.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicamen Biotech Ltd | 32.47m | 1.46m | 116.14m | 378.00 | 62.54 | -- | 47.73 | 3.58 | 8.11 | 8.11 | 160.31 | -- | -- | -- | -- | 4,772,797.00 | -- | 5.89 | -- | 8.45 | 46.89 | 36.54 | 3.52 | 9.58 | -- | 2.79 | -- | 8.46 | 27.29 | 7.90 | -26.36 | -1.89 | -16.71 | 0.00 |
| YSP Southeast Asia Holding Bhd | 126.36m | 10.80m | 118.00m | 519.00 | 10.93 | 0.8555 | 7.18 | 0.9338 | 0.2196 | 0.2196 | 2.57 | 2.81 | 0.68 | 1.52 | 5.43 | -- | 5.89 | 5.83 | 7.17 | 6.83 | 44.21 | 42.57 | 8.65 | 8.46 | 2.67 | 56.19 | 0.1143 | 39.47 | 6.21 | 4.22 | 8.27 | 4.22 | 4.29 | 2.71 |
| Vita Life Sciences Limited | 78.92m | 9.41m | 118.44m | 124.00 | 12.23 | 2.43 | 11.98 | 1.50 | 0.1717 | 0.1717 | 1.44 | 0.865 | 1.29 | 2.33 | 6.94 | -- | 15.37 | 15.25 | 21.18 | 21.99 | 58.48 | 60.90 | 11.90 | 11.71 | 2.18 | -- | 0.0088 | 39.05 | 10.88 | 12.50 | 28.18 | 30.07 | 12.15 | 19.14 |
| Ohki Healthcare Holdings Co Ltd | 3.39bn | 20.73m | 119.04m | 632.00 | 5.61 | 0.4092 | 5.04 | 0.0352 | 151.56 | 151.56 | 24,771.52 | 2,077.28 | 2.54 | 13.31 | 4.54 | 538,470,000.00 | 1.49 | 1.85 | 6.44 | 8.42 | 5.11 | 6.16 | 0.5859 | 0.7178 | 0.8853 | -- | 0.1698 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
| bluebird bio Inc | 83.40m | -473.10m | 119.51m | 375.00 | -- | 1.48 | -- | 1.43 | -2.19 | -2.19 | 0.3574 | 0.2733 | 0.0909 | 3.21 | -- | 146,400.00 | -51.54 | -34.75 | -80.31 | -40.84 | -37.34 | -124.35 | -567.29 | -5,770.41 | 0.5712 | -19.81 | 0.7827 | -- | 720.04 | -11.58 | 8.00 | -- | -30.47 | -- |
| IND Swift Laboratories Ltd | 180.65m | 72.83m | 119.64m | 47.00 | 1.64 | -- | 1.49 | 0.6623 | 68.53 | 68.53 | 170.41 | -- | -- | -- | -- | 213,559,000.00 | -- | 5.00 | -- | 6.13 | 47.54 | 41.12 | 40.36 | 8.52 | -- | 4.68 | -- | 0.00 | 6.10 | 11.10 | 784.44 | 70.82 | 23.60 | -- |
| Haemato AG | 424.65m | 15.65m | 120.16m | 78.00 | 7.63 | 0.49 | 6.86 | 0.283 | 1.84 | 1.84 | 50.10 | 28.67 | 1.47 | 9.80 | 12.48 | 3,343,690.00 | 5.41 | 2.01 | 6.45 | 2.70 | 7.56 | 8.42 | 3.68 | 1.21 | 1.66 | -- | 0.0203 | 157.20 | -12.95 | -3.03 | 25.39 | 3.32 | -5.75 | -16.74 |
| Holder | Shares | % Held |
|---|---|---|
| SG Hiscock & Co. Ltd.as of 09 Feb 2024 | 3.30m | 5.85% |
